Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1350 (LINC01350) is a non-coding RNA gene that does not code for a protein, but produces long transcripts longer than 200 nucleotides, classified as a long intergenic non-coding RNA (lincRNA)[1][3][5]. LincRNAs are distinct from protein-coding genes and are primarily involved in regulation of neighboring or distal gene expression through various mechanisms, including chromatin remodeling, transcriptional regulation, and RNA stabilization[5][7]. While lincRNAs as a class have growing evidence of functional significance in gene regulatory networks and diseases such as cancer, there is currently limited or no direct evidence implicating LINC01350 as a validated therapeutic target or direct biomarker in any disease context[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1350 (LINC01350).